V023-2830 Screening compound: 2-[4-(3-methoxybenzoyl)piperazin-1-yl]-6-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one

V023-2830 Screening compound: 2-[4-(3-methoxybenzoyl)piperazin-1-yl]-6-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one
V023-2830 Screening compound: 2-[4-(3-methoxybenzoyl)piperazin-1-yl]-6-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound V023-2830
2-[4-(3-methoxybenzoyl)piperazin-1-yl]-6-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V023-2830

Molecular Formula

C28H34N6O4 (C28 H34 N6 O4)

Compound Name

2-[4-(3-methoxybenzoyl)piperazin-1-yl]-6-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one

IUPAC name

2-[4-(3-methoxybenzoyl)piperazin-1-yl]-6-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-34-dihydropyrimidin-4-one

SMILES

COc1cccc(C(N(CC2)CCN2C(N2)=NC(CN(CC3)CCN3c(cccc3)c3OC)=CC2=O)=O)c1

InChI

InChI=1S/C28H34N6O4/c1-37-23-7-5-6-21(18-23)27(36)33-14-16-34(17-15-33)28-29-22(19-26(35)30-28)20-31-10-12-32(13-11-31)24-8-3-4-9-25(24)38-2/h3-9,18-19H,10-17,20H2,1-2H3,(H,29,30,35)

InChI Key

WVNQIRDANHOXLZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19859477

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

518.62

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.923

Distribution Coefficient, logD

0.671

Water Solubility, LogSw

-2.78

Polar Surface Area

76.685

Acid Dissociation Constant (pKa)

8.87

Base Dissociation Constant (pKb)

7.65

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

39.29

V023-2830 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer

References: we are preparing a list of scientific research reports with V023-2830 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V023-2830?
Check Price and Availability of V023-2830, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V023-2830 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V023-2830
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V023-2830
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V023-2830 available by request